bta04722: Neurotrophin signaling pathway |
30 |
3.4E-03 |
bta05211: Renal cell carcinoma |
19 |
5.3E-03 |
bta04666:Fc gamma R-mediated phagocytosis |
23 |
6.2E-03 |
bta05218: Melanoma |
19 |
6.3E-03 |
bta04130: SNARE interactions in vesicular transport |
13 |
7.0E-03 |
bta04810: Regulation of actin cytoskeleton |
41 |
1.2 E-02 |
bta05200: Pathways in cancer |
60 |
1.5 E-02 |
bta04010: MAPK signaling pathway |
52 |
1.6 E-02 |
bta04660:T cell receptor signaling pathway |
25 |
1.8 E-02 |
bta04110: Cell cycle |
28 |
2.1 E-02 |
bta04142: Lysosome |
26 |
2.4 E-02 |
bta05214: Glioma |
16 |
2.7 E-02 |
bta05216: Thyroid cancer |
9 |
3.0 E-02 |
bta04115:p53 signaling pathway |
16 |
3.0 E-02 |
bta04150:mTOR signaling pathway |
14 |
3.2 E-02 |
bta04620: Toll-like receptor signaling pathway |
22 |
3.3 E-02 |
bta04670: Leukocyte transendothelial migration |
24 |
6.3 E-02 |
bta05212: Pancreatic cancer |
16 |
6.4 E-02 |
bta00601: Glycosphingolipid biosynthesis |
8 |
6.7 E-02 |
bta04664:Fc epsilon RI signaling pathway |
17 |
6.7 E-02 |
bta00510:N-Glycan biosynthesis |
11 |
7.3 E-02 |
bta03040: Spliceosome |
25 |
8.7 E-02 |
bta05219: Bladder cancer |
10 |
8.8 E-02 |
bta04210: Apoptosis |
18 |
9.3E-02 |
bta03018: RNA degradation |
13 |
9.6E-02 |